Healthcare Industry News:  Cepheid 

Diagnostics Personnel

 News Release - February 11, 2008

Cepheid Appoints Senior VP, Chief Financial Officer to Management Team

SUNNYVALE, Calif., Feb. 11 (HSMN NewsFeed) -- Cepheid (Nasdaq: CPHD ) today announced that Andrew D. Miller will be joining Cepheid as Senior Vice President, Chief Financial Officer on April 14, 2008, and will assume responsibility for worldwide financial operations and investor relations. Mr. Miller will report to John L. Bishop, Chief Executive Officer, and replaces John Sluis, who retired from Cepheid effective December 31, 2007.

Mr. Miller comes to Cepheid from Autodesk where he serves as Vice President and Chief Accounting Officer. In this role, Mr. Miller has led Autodesk's worldwide accounting, compliance, SEC reporting, and Sarbanes-Oxley 404 activities with responsibility for delivering financial services globally for this Nasdaq-listed software entity with more than $1.8B in revenues last year.

Prior to joining Autodesk, Mr. Miller was Senior Vice President and CFO for MarketFirst Software, Inc., a leading provider of enterprise marketing automation software. Other previous experience includes Vice President of Worldwide Finance for Cadence Design Systems, and Vice President of Finance and Corporate Controller for Adaptive Broadband Corporation where he was responsible for worldwide finance, accounting, and treasury functions. He also worked at Silicon Graphics, Inc., serving in a series of key senior finance, administration, and operations roles. Prior to SGI, he held various corporate and divisional finance management roles at Network Equipment Technologies.

Mr. Miller began his career as a CPA with Deloitte and Touche, serving many large technology companies. He graduated Summa Cum Laude from Santa Clara University with a Bachelors of Science in Commerce and holds a CPA from the state of California.

"We are extremely pleased to have Andy as a member of the Cepheid management team. He brings a significant track record of success in building financial teams and in implementing systems in high growth and large business operations. His skill sets are expected to be a strong complement to Cepheid's high growth environment," said John Bishop, Cepheid's Chief Executive Officer.

About Cepheid

Based in Sunnyvale, Calif., Cepheid (Nasdaq: CPHD ) is an on-demand molecular diagnostics company that develops, manufactures and markets fully-integrated systems for genetic analysis in the clinical, industrial and biothreat markets. The company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The company's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprietary test cartridges. Through its strong molecular biology capabilities, the company is focusing on those applications where rapid molecular testing is particularly important, such as identifying infectious disease and cancer in the clinical market; food, agricultural, and environmental testing in the industrial market; and identifying bio-terrorism agents in the biothreat market. See http://www.Cepheid.com for more information.


Source: Cepheid

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.